Hamdok to Asharq Al-Awsat: Manama Agreement Complements Jeddah Platform

Former Sudanese Prime Minister Abdalla Hamdok
Former Sudanese Prime Minister Abdalla Hamdok
TT

Hamdok to Asharq Al-Awsat: Manama Agreement Complements Jeddah Platform

Former Sudanese Prime Minister Abdalla Hamdok
Former Sudanese Prime Minister Abdalla Hamdok

Former Sudanese Prime Minister Abdalla Hamdok described the agreement between the Deputy Commander-in-Chief of the Army, Lieutenant General Shams al-Din al-Kabbashi, and Deputy Commander of the Rapid Support Forces (RSF) Lieutenant General Abdul Rahim Dagalo in Manama last month as a positive step in the right direction.

He said the agreement complements the Jeddah Platform talks, which are greatly relied upon to stop the devastating war in Sudan.

In an interview with Asharq Al-Awsat and a limited number of journalists, on the sidelines of the African Union summit in Addis Ababa, Hamdok demanded that these efforts go hand in hand with a political process in Africa, under the supervision of the Intergovernmental Authority on Development (IGAD) and the African Union.

He said he stressed to AU leaders that a military solution would not solve the Sudanese war unless there is support for a political process to address the crisis through negotiations.

Hamdok also discussed the “catastrophic humanitarian situation” in his country, saying that 25 million people were facing hunger because of war.

“We have called on the international community for the necessity of allowing access of humanitarian aid through the Sudanese borders with Chad, Ethiopia and South Sudan, to alleviate the suffering of the people,” he underlined.

The former prime minister talked about political and security chaos in the region, saying: “In addition to war in Gaza, there are tensions in the Red Sea... A direct intervention in this conflict would further increase this polarization.”

On the internal situation in Sudan, Hamdok told the journalists that he maintained communication with the Army leadership to hold a meeting between the two sides of the conflict.

“We have not yet reached a final decision about the date of the meeting, but we hope that it will take place in an imminent and urgent manner. We have also stressed the need to limit the hostile rhetoric ... to create the appropriate environment for the talks,” he said.

The Sudanese official reiterated that the goal of the talks was to end the war and the suffering of the Sudanese people.

“We hope that formalities would not be an obstacle,” he stated.

Asked about the implementation of the clauses stipulated in the Addis Ababa declaration, Hamdok said that he emphasized the need to execute the practical aspects of the agreement, in particular the pledge to release 451 war prisoners.

He noted that the RSF leadership has expressed willingness to release the detainees but has claimed that it was encountering a problem with the departure of the Red Cross teams from the country.

The former Sudanese prime minister asserted that most political parties in the country have voiced their keenness on the unity of the democratic forces, but that work within alliances required patience and perseverance in order to be sustainable.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.